Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial
Titel:
Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial
Auteur:
Brown, David M Boyer, David S Do, Diana V Wykoff, Charles C Sakamoto, Taiji Win, Peter Joshi, Sunir Salehi-Had, Hani Seres, AndrĂ¡s Berliner, Alyson J Leal, Sergio Vitti, Robert Chu, Karen W Reed, Kimberly Rao, Rohini Cheng, Yenchieh Sun, Wei Voronca, Delia Bhore, Rafia Schmidt-Ott, Ursula Schmelter, Thomas Schulze, Andrea Zhang, Xin Hirshberg, Boaz Yancopoulos, George D Sivaprasad, Sobha